Development of a novel dual JAK/Src kinase inhibitor
Development of a novel dual JAK/Src kinase inhibitor
Inhibitors of both JAK and Src kinases represent promising targets for cancer therapeutics because of the central importance of these kinases in tumor cell proliferation and survival. Furthermore, in cancer cells activation ...